CREATINE KINASE ISOENZYME (CK-MB) TEST KIT (IMMUNOFLUORESCENCE)
KIT PARA DETERMINACIÓN CUANTITATIVA IN VITRO DEL CONTENIDO DE CREATINA CINASA ISOENZIMA (CK-MB) EN SUERO HUMANO, PLASMA O SANGRE COMPLETA. AGENTE DE DIAGNÓSTICO IN VITRO. PARA USO EXCLUSIVO DE LABORATORIOS CLÍNICOS O DE GABINETE.
KIT FOR QUANTITATIVE IN VITRO DETERMINATION OF CREATINE KINASE ISOENZYME CONTENT (CK-MB) IN HUMAN SERUM, PLASMA OR WHOLE BLOOD. IN VITRO DIAGNOSTIC AGENT. FOR USE OF CLINICAL OR CABINET LABORATORIES ONLY.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE CREATINA CINASA ISOENZIMA (CK-MB).
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF CREATINE KINASE ISOENZYME (CK-MB).
- Analysis ID
- 2093R2019 SSA
- Registration Date
- November 06, 2019
- Name (Spanish)
- ATYDE MÉXICO, S.A. DE C.V.
- Name (English)
- ATYDE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CREATINE KINASE ISOENZYME (CK-MB) TEST KIT (IMMUNOFLUORESCENCE) (CREATINE KINASE ISOENZYME (CK-MB) TEST KIT (IMMUNOFLUORESCENCE)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2093R2019 SSA and manufactured by ATYDE MÉXICO, S.A. DE C.V.. The device was registered on November 06, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.